|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/44 | |
| G01N 33/94 |
| (11) | Patento numeris | 2888592 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13831507.2 |
| Europos patento paraiškos padavimo data | 2013-08-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-07-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/055834 |
| Data | 2013-08-20 |
| (87) | Numeris | WO 2014/031668 |
| Data | 2014-02-27 |
| (30) | Numeris | Data | Šalis |
| 201261691659 P | 2012-08-21 | US |
| (72) |
HRYHORENKO, Eric, US
SANKARAN, Banumathi, US
DECORY, Thomas R., US
TUBBS, Theresa, US
COLT, Linda, US
REMMERIE, Bart M., BE
SALTER, Rhys, US
DONAHUE, Matthew Garrett, US
GONG, Yong, US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | ANTIBODIES TO QUETIAPINE AND USE THEREOF |
| ANTIBODIES TO QUETIAPINE AND USE THEREOF |